These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24746454)

  • 21. Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall.
    Fischer-Valuck BW; Chundury A; Gay H; Bosch W; Michalski J
    Pract Radiat Oncol; 2017; 7(3):195-202. PubMed ID: 28089528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of two different rectal spacers in prostate cancer external beam radiotherapy in terms of rectal sparing and volume consistency.
    Wolf F; Gaisberger C; Ziegler I; Krenn E; Scherer P; Hruby S; Schätz T; Forstner R; Holzinger J; Vaszi A; Kametriser G; Steininger P; Deutschmann H; Sedlmayer F
    Radiother Oncol; 2015 Aug; 116(2):221-5. PubMed ID: 26232129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current role of spacers for prostate cancer radiotherapy.
    Pinkawa M
    World J Clin Oncol; 2015 Dec; 6(6):189-93. PubMed ID: 26677428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: results of a multi-institutional phase II trial.
    Uhl M; van Triest B; Eble MJ; Weber DC; Herfarth K; De Weese TL
    Radiother Oncol; 2013 Feb; 106(2):215-9. PubMed ID: 23333011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interstitial biodegradable balloon for reduced rectal dose during prostate radiotherapy: results of a virtual planning investigation based on the pre- and post-implant imaging data of an international multicenter study.
    Melchert C; Gez E; Bohlen G; Scarzello G; Koziol I; Anscher M; Cytron S; Paz A; Torre T; Bassignani M; Dal Moro F; Jocham D; Yosef RB; Corn BW; Kovács G
    Radiother Oncol; 2013 Feb; 106(2):210-4. PubMed ID: 23484879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published Data.
    Karsh LI; Gross ET; Pieczonka CM; Aliotta PJ; Skomra CJ; Ponsky LE; Nieh PT; Han M; Hamstra DA; Shore ND
    Urology; 2018 May; 115():39-44. PubMed ID: 29174940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of rectal displacement devices during prostate external-beam radiation therapy: A review.
    Sanei M; Ghaffari H; Ardekani MA; Mahdavi SR; Mofid B; Abdollahi H; Rostami A
    J Cancer Res Ther; 2021; 17(2):303-310. PubMed ID: 34121672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First report of transperineal polyethylene glycol hydrogel spacer use to curtail rectal radiation dose after permanent iodine-125 prostate brachytherapy.
    Beydoun N; Bucci JA; Chin YS; Malouf D; Enari E; Painter SD
    Brachytherapy; 2013; 12(4):368-74. PubMed ID: 23453682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapy.
    Chapet O; Udrescu C; Tanguy R; Ruffion A; Fenoglietto P; Sotton MP; Devonec M; Colombel M; Jalade P; Azria D
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):425-32. PubMed ID: 24411613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patients.
    Shiraishi Y; Yorozu A; Ohashi T; Toya K; Seki S; Yoshida K; Kaneda T; Saito S; Nishiyama T; Hanada T; Shigematsu N
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e127-33. PubMed ID: 21398047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organ movements and dose exposures in teletherapy of prostate cancer using a rectal balloon.
    Elsayed H; Bölling T; Moustakis C; Müller SB; Schüller P; Ernst I; Willich N; Könemann S
    Strahlenther Onkol; 2007 Nov; 183(11):617-24. PubMed ID: 17960337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of prostate-rectum separation on rectal dose from external beam radiotherapy.
    Susil RC; McNutt TR; DeWeese TL; Song D
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1251-8. PubMed ID: 19939577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
    Nitsche M; Brannath W; Brückner M; Wagner D; Kaltenborn A; Temme N; Hermann RM
    Br J Radiol; 2017 Feb; 90(1070):20160370. PubMed ID: 27936891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy±intensity modulated radiation therapy.
    Strom TJ; Wilder RB; Fernandez DC; Mellon EA; Saini AS; Hunt DC; Pow-Sang JM; Spiess PE; Sexton WJ; Poch MA; Biagioli MC
    Radiother Oncol; 2014 Apr; 111(1):126-31. PubMed ID: 24746567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy.
    Hwang ME; Black PJ; Elliston CD; Wolthuis BA; Smith DR; Wu CC; Wenske S; Deutsch I
    Radiat Oncol; 2018 Oct; 13(1):192. PubMed ID: 30285812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
    Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyethylene glycol-based hydrogel rectal spacers for prostate brachytherapy: a systematic review with a focus on technique.
    Vaggers S; Rai BP; Chedgy ECP; de la Taille A; Somani BK
    World J Urol; 2021 Jun; 39(6):1769-1780. PubMed ID: 32840655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI findings of absorbable hydrogel spacer for prostate cancer therapy: a pictorial review.
    Rohr A; Werth K; Shen X; Collins Z; Fishback S; Jones J; Ash R; Williams V
    Abdom Radiol (NY); 2019 Jan; 44(1):247-251. PubMed ID: 29967983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity-modulated brachytherapy or EBRT for prostate cancer patients: in regard to Prada et al. (Int J Radiat Oncol Biol Phys 2007;69:95-102.).
    Vordermark D; Guckenberger M; Baier K; Markert K
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):316-7. PubMed ID: 18406899
    [No Abstract]   [Full Text] [Related]  

  • 40. Rectal ulcer associated with SpaceOAR hydrogel insertion during prostate brachytherapy.
    Teh AY; Ko HT; Barr G; Woo HH
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25535226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.